Lucas Alfredo Defelipe

Lucas Alfredo Defelipe

Auto-generated profile, based on publicly available information

Lucas Alfredo Defelipe

European Molecular Biology Laboratory, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2017 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
JAJuan Pablo Arcon
Juan Pablo Arcon
LDLucas A. Defelipe
Lucas A. Defelipe
CMCarlos Modenutti
Carlos Modenutti
ELElias D. López
Elias D. López
DADaniel Alvarez-Garcia
Daniel Alvarez-Garcia
MMMarcelo A. Marti
Marcelo A. Marti

2 March 2019 in Bioinformatics
Verified
Journal Article
Closed access
JAJuan Pablo Arcon
Juan Pablo Arcon
CMCarlos Modenutti
Carlos Modenutti
DADemian Avendaño
Demian Avendaño
ELElias D Lopez
Elias D Lopez
LDLucas A Defelipe
Lucas A Defelipe
MMMarcelo A. Marti
Marcelo A. Marti
Summary: The performance of docking calculations can be improved by tuning parameters for the system of interest, e.g. biasing the results towards the formation of relevant protein–ligand interactions, such as known ligand pharmacophore or interaction sites derived from cosolvent molecular dynamics. AutoDock Bias is a straightforward and easy to use script-based method that allows the introduction of different types of user-defined biases for fine-tuning AutoDock4 docking calculations. Availability and implementation: AutoDock Bias is distributed with MGLTools (since version 1.5.7), and freely available on the web at http://ccsb.scripps.edu/mgltools/ or http://autodockbias.wordpress.com. Supplementary information: Supplementary data are available at Bioinformatics online.

16 June 2014 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
GCGeorgina A. Cardama
Georgina A. Cardama
MCMaria J. Comin
Maria J. Comin
LHLeandro Hornos
Leandro Hornos
NGNazareno Gonzalez
Nazareno Gonzalez
LDLucas Defelipe
Lucas Defelipe
PMPablo Lorenzano Menna
Pablo Lorenzano Menna
Rho GTPases play a key role in the regulation of multiple essential cellular processes, including actin dynamics, gene transcription and cell cycle progression. Aberrant activation of Rac1, a member of Rho family of small GTPases, is associated with tumorigenesis, cancer progression, invasion and metastasis. Particularly, Rac1 is overexpressed and hyperactivated in highly aggressive breast cancer. Thus, Rac1 appears to be a promising and relevant target for the development of novel anticancer drugs. We identified the novel Rac1 inhibitor ZINC69391 through a docking-based virtual library screening targeting Rac1 activation by GEFs. This compound was able to block Rac1 interaction with its GEF Tiam1, prevented EGF-induced Rac1 activation and inhibited cell proliferation, cell migration and cell cycle progression in highly aggressive breast cancer cell lines. Moreover, ZINC69391 showed an in vivo antimetastatic effect in a syngeneic animal model. We further developed the novel analog 1A-116 by rational design and showed to be specific and more potent than the parental compound in vitro and interfered Rac1-P-Rex1 interaction. We also showed an enhanced in vivo potency of 1A-116 analog. These results show that we have developed novel Rac1 inhibitors that may be used as a novel anticancer therapy.

1 April 2011 in Insect Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
LDL.A. Defelipe
L.A. Defelipe
EDE. Dolghih
E. Dolghih
ARA.E. Roitberg
A.E. Roitberg
MNM. Nouzova
M. Nouzova
JMJ.G. Mayoral
J.G. Mayoral
ATAdrián G. Turjanski
Adrián G. Turjanski

24 September 2021 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Open access
PDF file
OBOsvaldo Burastero
Osvaldo Burastero
SNStephan Niebling
Stephan Niebling
LDLucas A. Defelipe
Lucas A. Defelipe
CGChristian Günther
Christian Günther
ASAngelica Struve
Angelica Struve
MAMaria M. Garcia Alai
Maria M. Garcia Alai
All biological processes rely on the formation of protein–ligand, protein–peptide and protein–protein complexes. Studying the affinity, kinetics and thermodynamics of binding between these pairs is critical for understanding basic cellular mechanisms. Many different technologies have been designed for probing interactions between biomolecules, each based on measuring different signals (fluorescence, heat, thermophoresis, scattering and interference, among others). Evaluation of the data from binding experiments and their fitting is an essential step towards the quantification of binding affinities. Here, user-friendly online tools to analyze biophysical data from steady-state fluorescence spectroscopy, microscale thermophoresis and differential scanning fluorimetry experiments are presented. The modules of the data-analysis platform (https://spc.embl-hamburg.de/) contain classical thermodynamic models and clear user guidelines for the determination of equilibrium dissociation constants (Kd) and thermal unfolding parameters such as melting temperatures (Tm).

2 November 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ESEzequiel J Sosa
Ezequiel J Sosa
GBGermán Burguener
Germán Burguener
ELEsteban Lanzarotti
Esteban Lanzarotti
LDLucas Defelipe
Lucas Defelipe
LRLeandro Radusky
Leandro Radusky
DPDario Fernández Do Porto
Dario Fernández Do Porto
Available genomic data for pathogens has created new opportunities for drug discovery and development to fight them, including new resistant and multiresistant strains. In particular structural data must be integrated with both, gene information and experimental results. In this sense, there is a lack of an online resource that allows genome wide-based data consolidation from diverse sources together with thorough bioinformatic analysis that allows easy filtering and scoring for fast target selection for drug discovery. Here, we present Target-Pathogen database (http://target.sbg.qb.fcen.uba.ar/patho), designed and developed as an online resource that allows the integration and weighting of protein information such as: function, metabolic role, off-targeting, structural properties including druggability, essentiality and omic experiments, to facilitate the identification and prioritization of candidate drug targets in pathogens. We include in the database 10 genomes of some of the most relevant microorganisms for human health (Mycobacterium tuberculosis, Mycobacterium leprae, Klebsiella pneumoniae, Plasmodium vivax, Toxoplasma gondii, Leishmania major, Wolbachia bancrofti, Trypanosoma brucei, Shigella dysenteriae and Schistosoma Smanosoni) and show its applicability. New genomes can be uploaded upon request.